#NABP #Enters #Final #Development #Phase #DSCSA
MOUNT PROSPECT, IL, Oct. 10, 2022 (GLOBE NEWSWIRE) — The National Association of Boards of Pharmacy® (NABP®) announced today that it is entering the final phase of development for its new network to facilitate supply chain interoperability. The network will provide a means for state regulators and trading partners to investigate and remove suspect or illegitimate medications from the legitimate supply chain. NABP was exploring how to address the Drug Supply Chain Security Act’s (DSCSA’s) upcoming interoperability requirements. The Association began working on the network after stakeholders from across the industry requested assistance identifying and addressing gaps in interoperability among all sectors and state regulators.
Passed by Congress in 2013, the requirements in DSCSA are intended to further protect the United States prescription drug supply chain, and the patients who use it, from substandard or falsified medications. The law has already triggered several implementation milestones since its passage, but several important provisions will go into effect in November 2023.
As the pharmaceutical supply chain prepares to comply with the November 2023 requirements, state regulatory authorities are preparing to support implementation of the law. A key requirement that NABP’s DSCSA network addresses is the requirement to electronically track and make available prescription drugs’ ownership transaction records. While participation is voluntary, the network will serve as a critical information sharing tool to help state regulators and trading partners ensure the legitimacy of prescription medications via electronic interoperability.
“The state boards of pharmacy play a critical role in protecting our nation’s drug supply. When the requirements of DSCSA are fully implemented in November 2023, it will be necessary for regulators to have an efficient means of communicating with manufacturers, wholesale distributors, pharmacies, and…
